News from eli lilly and company A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
06:45 ET Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has granted...
Mar 12, 2020, 18:11 ET AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
AbCellera and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop antibody products for the treatment ...
Mar 12, 2020, 08:00 ET US FDA grants Fast Track designation to Jardiance® for the treatment of chronic kidney disease
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of Jardiance® (empagliflozin) to reduce the risk ...
Mar 11, 2020, 12:36 ET Lilly to Participate in New Model Designed to Make Insulins More Affordable for Seniors in Medicare Part D
Eli Lilly and Company (NYSE: LLY) is proud to announce its planned participation in the new Part D Senior Savings Model, announced today by the...
Mar 09, 2020, 12:10 ET Lilly to Participate in Barclays Global Healthcare Conference
Eli Lilly and Company (NYSE:LLY) will participate in the Barclays Global Healthcare Conference on Tuesday, March 10, 2020. Ilya Yuffa, vice...
Mar 03, 2020, 07:00 ET Lilly Statement on Novel Coronavirus and the Reliable Supply of the Company's Medicines
Eli Lilly and Company (NYSE: LLY) issued the following statement today regarding the novel coronavirus: Among the concerns raised due to the impact...
Mar 02, 2020, 06:45 ET U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a...
Feb 26, 2020, 19:27 ET FDA Advisory Committee Votes in Favor of Lilly's CYRAMZA® (ramucirumab) as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Eli Lilly and Company (NYSE: LLY) today announced that a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 6-5...
Feb 21, 2020, 19:50 ET Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease
The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in...
Feb 21, 2020, 15:45 ET Lilly to Participate in Cowen Health Care Conference
Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 40th Annual Health Care Conference on Tuesday, March 3, 2020. Joshua...
Feb 21, 2020, 15:10 ET Lilly To Participate in SVB Leerink Global Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February 27, 2020. Patrik...
Feb 20, 2020, 08:55 ET Lilly Completes Acquisition of Dermira
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition...
Feb 10, 2020, 01:00 ET Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Eli Lilly and Company (NYSE: LLY) today announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited ...
Feb 07, 2020, 14:00 ET Lilly to Participate in Guggenheim Healthcare Talks Idea Forum
Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Healthcare Talks Idea Forum on Thursday, February 13, 2020. Jacob Van Naarden,...
Jan 31, 2020, 06:15 ET CHMP Recommends Approval of Lilly's New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes
Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...
Jan 30, 2020, 06:25 ET Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2019. $ in millions, except per share...
Jan 30, 2020, 06:15 ET Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that baricitinib met the primary endpoint in BREEZE-AD5, an...
Jan 29, 2020, 06:45 ET Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug...
Jan 28, 2020, 06:45 ET Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct...
Jan 27, 2020, 17:34 ET US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved Trijardy™ XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) to ...
Jan 27, 2020, 06:45 ET Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that baricitinib met the primary endpoint in BREEZE-AD4, an...
Jan 24, 2020, 06:30 ET Anat Hakim to join Lilly as General Counsel
Eli Lilly and Company (NYSE: LLY) announced today that Anat Hakim will join the company on February 3, 2020 as senior vice-president and general...
Jan 21, 2020, 12:47 ET Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant
Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs ...
Jan 16, 2020, 15:45 ET Lilly Confirms Date and Conference Call for Fourth-Quarter 2019 Financial Results Announcement
Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020. Lilly will...
Jan 15, 2020, 06:45 ET Lilly, Anna Kaiser Launch '30-Day Thriver Challenge' to Increase Awareness of Daily Stress of Living with Metastatic Breast Cancer, Elevate Support for Women and Men Living with the Disease
- An estimated 113 people die every day in the U.S. from metastatic breast cancer (MBC).1 This devastating statistic adds to the emotional and mental ...
